We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Blood Donor Plasma Screened for Viral Antibodies

By LabMedica International staff writers
Posted on 02 May 2011
An enzyme immunoassay kit revealed that a proportion of blood donors in France have been exposed to the Toscana virus (TOSV).

The presence of immunoglobulin G (IgG) and IgM against TOSV in the plasma of the donors suggests a potential risk for transmitting the virus through blood transfusion or organ transplantation.

Scientists at the University of the Mediterranean, (Marseille, France), tested the plasma collected from 729 blood donors in seven French territorial divisions during the summer of 2007 for the presence of TOSV antibodies. A commercial enzyme immunoassay (EIA) kit was developed by using the recombinant nucleocapsid (N) protein of TOSV. This serologic test had been validated in a previous study that revealed high specificity and sensitivity.

The results showed that 84/729 (11.5%) plasma samples were positive for IgG against TOSV N protein. Twenty-four (3.3%) plasma samples were positive for IgM and five (0.7%) were positive for both IgG and IgM. To confirm the results, the IgG-positive samples were further subjected to Western blot (WB) analysis by using the TOSV isolate H/IMTSSA infected cell lysate. In 233 (32%) of the samples, protein of molecular mass compatible with that of the N protein was detected.

To detect TOSV ribonucleic acid (RNA), the investigators processed IgM-positive plasma samples by reverse transcription–polymerase chain reaction (RT-PCR). The finding of IgM is an indication of a recent exposure to the virus and hence its possible presence in blood. The RT-PCR did not detect any viral RNA in the samples. These negative results could indicate either cleared viremia or a low viral load, below the sensitivity limit of the test. TOSV prevalence in Corsica, an island in the Mediterranean Sea, was unexpectedly high. In this region, 10 of the 115 donors, (8.7%), of the population sampled showed an IgG- or IgM-positive response. In the other districts, the IgM seroprevalence did not exceed 4.4%.

The commercial enzyme immunoassay kit used is known as the EIA Enzywell Toscana virus IgG and IgM, and produced by DIESSE Diagnostica Senese S.p.A.; Siena, Italy).

Toscana virus is an arthropod-borne RNA virus (family Bunyaviridae and genus Phlebovirus) transmitted by phlebotomine sand flies in Mediterranean countries. TOSV causes acute meningitis and meningoencephalitis in patients. The study was published in May 2011, in the journal Emerging Infectious Diseases.

Related Links:
University of the Mediterranean
DIESSE Diagnostica Senese S.p.A



Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay
New
Liquid Based Cytology Production Machine
LBP-4032

Latest Hematology News

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients